期刊文献+

探讨分化型甲状腺癌围手术期循环血微转移相关因素分析 被引量:2

Correlative factors of preoperative circulatory blood micrometastasis in differentiated thyroid carcinoma
下载PDF
导出
摘要 目的 探讨分化型甲状腺癌围手术期循环血微转移的发生情况及其影响因素.方法 随机选取本院2013年7月至2015年6月期间收治的分化型甲状腺癌患者164例,采用流式细胞术对其进行围手术期外周血微转移检查,并对其相关影响因素进行分析.结果 术前循环血微转移同淋巴结分期(x2=-4.622,P=0.032)和肿瘤大小(x2=4.429,P=0.035)之间存在明显相关性(P<0.05),而同肿瘤分化程度并无明显关系(x 2=2.023,P=0.155);术后循环血微转移阳性仅同肿瘤的分化程度有关(x2=4.409,P=0.036),同淋巴结分期(x2=1.218,P=0.270)和肿瘤大小(x2=0.980,P=0.322)并无明显相关性.结论 分化型甲状腺癌患者循环血微转移的发生与手术刺激、淋巴结分期和肿瘤大小之间存在密切关系,其中肿瘤分化程度是造成此类患者持续存在血微转移的重要因素. Objective To investigate the incidence of preoperative circulatory blood micrometastasis in differentiated thyroid carcinoma and the relevant factors.Methods The clinical data of 164 thyroid carcinoma patients admitted into our hospital from July,2013 to June,2015 was randomly collected.Peripheral blood micrometastasis was checked with flow cytometry.The relevant factors of the micrometastasis were analyzed.Results The preoperative circulatory blood micrometastasis obviously correlated with lymph node staging (x2=-4.622,P=0.032) and tumor size (x 2=4.429,P=-0.035) but not with tumor differentiation (x2=2.023,P=-0.155);the positivity of postoperative circulatory blood micrometastasis only correlated with tumor differentiation (x2=4.409,P=0.036〈0.05) but not with lymph node staging (x2=1.218,P=0.270) and tumor size (x2=0.980,P=0.322).Conclusions The incidence of circulatory blood micrometastasis in preoperative thyroid carcinoma patients has close relationship with surgical stimulation,lymph node staging,and tumor size.While,the degree of tumor differentiation is an important factor in this kind of continuous blood mircrometastasis patients.
作者 贺亮
出处 《国际医药卫生导报》 2016年第14期2092-2095,共4页 International Medicine and Health Guidance News
关键词 分化型甲状腺癌 血微转移 流式细胞术 Differentiated thyroid carcinoma Blood mircrometastasis Flow cytometry Differentiated thyroid carcinoma Blood mircrometastasis Flow cytometry
  • 相关文献

参考文献7

二级参考文献70

  • 1刘洪枫,唐伟松,杨志英.甲状腺钙化性病灶与甲状腺癌[J].中国医学科学院学报,2003,25(5):626-629. 被引量:147
  • 2袁耿彪,匡安仁,黄蕤,彭伟凯,王全林,管昌田.分化型甲状腺癌术后随访中停用左旋甲状腺素2周的临床价值[J].中华核医学杂志,2006,26(3):152-155. 被引量:6
  • 3纪小龙,吉米.甲状腺病理诊断[M].北京:人民军医出版社.2011:131-135.
  • 4汤钊猷.现代肿瘤学[M].第3版,上海:复旦大学出版社,2011:203-204.
  • 5Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001 [ J] CA Cancer J Clin, 2001, 51 ( 1 ) : 15-36.
  • 6Astl J, Dvor6kova M, Vlcek P, et al. Thyroid surgery in children and adolescents [ J 1. Int J Pediatr Otorhinolaryngol, 2004, 68 (10) :1273-1278.
  • 7Steliarova-Foucher E, Stiller CA, Pukkala E, et al. Thyroid cancer incidence and survival among European children and adolescents( 1978-1997 ) : Report from the Automated Childhood Cancer Information System project [ J]. Eur J Cancer, 2006, 42 (13) :2150-2169.
  • 8Vesely D, Astl J, Matucha P, et al. Serum levels of angiogenic growth factors in patients with thyroid gland tumors and parathyroid adenoma[ J]. Neuroendocrinol Lett, 2003, 24 (6) :417-419.
  • 9Moore SW, Appfelstaedt J, Zaahl MG. Familial medullaa'y carcinoma prevention, risk evaluation, and RET in children of families with MEN2[J]. J Pediatr Surg, 2007,42(2) : 326-332.
  • 10Fassina AS, M. Rupolo M, Pelizzo MR, et al. Thyroid cancer in children and adolescents[J]. Tumori, 1994, 80(4): 257-262.

共引文献41

同被引文献24

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部